每周股票复盘：稳健医疗（300888）2024年营收89.8亿，同比增长9.7%

Core Viewpoint - The company,稳健医疗, reported a decline in stock price and provided key financial performance metrics for 2024, indicating growth in revenue and net profit despite a slight decrease in stock value [1][2]. Group 1: Financial Performance - In 2024, the company achieved a total revenue of 8.98 billion yuan, representing a year-on-year growth of 9.7%. Excluding infection prevention products, revenue reached 8.62 billion yuan, with an 18.6% increase [2][4]. - The net profit attributable to shareholders for the year was 700 million yuan, with a 19.8% year-on-year growth. After excluding non-recurring gains and losses, the net profit was 590 million yuan, reflecting a 43.4% increase [2][4]. - The diluted earnings per share for 2024 was 1.19 yuan, marking a 21.43% increase compared to the previous year [2]. Group 2: Cash Flow and Returns - The net cash flow from operating activities was 1.263 billion yuan [4]. - The weighted average return on equity was 6.07%, an increase of 1.04 percentage points year-on-year [2]. Group 3: Dividend Distribution - The board approved a cash dividend distribution plan of 2.50 yuan per 10 shares, with a record date of May 29, 2025, and an ex-dividend date of May 30, 2025 [3]. - The minimum price for share reduction was adjusted to 48.90 yuan per share, and the grant price for restricted stock incentive plans was set at 15.14 yuan per share [3].